Blood Preparation Market to Reach USD 73 Billion by 2030, Growing at a CAGR of 6%
According to Next Move Strategy Consulting, the global Blood Preparation Market is poised for significant growth, with a projected market size of USD 73 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6% by 2030. Blood preparation refers to the critical process of collecting, testing, processing, and storing blood and its components, which are essential for transfusions and therapeutic treatments. This process ensures safety and efficacy in medical procedures that require blood-based products.
Download Free Sample: https://www.nextmsc.com/blood-preparation-market/request-sample
Market Dynamics and Trends
Advancements in blood processing technologies, such as centrifugal separation, have propelled the growth of the blood preparation market. Furthermore, the increasing use of plasma-based therapies, including products like Albumin and Intravenous Immunoglobulin (IVIg), has contributed to expanding applications in the treatment of immune deficiencies and various blood disorders. These therapies are particularly vital for patients suffering from conditions such as Hereditary Angioedema and Hemophilia, further driving market expansion.
However, challenges remain, particularly the risk of disease transmission through blood transfusions, including viral hemorrhagic fever, HIV, and hepatitis B, which continues to hamper market growth. Additionally, allergic reactions during blood transfusions, such as hypotensive transfusion reactions, pose ongoing concerns.
Despite these challenges, the rise of innovative technologies, including automated blood collection systems, promises to enhance processing efficiency and improve product quality. These developments are expected to present ample growth opportunities for the market in the years to come.
Inquire Before Buying: https://www.nextmsc.com/blood-preparation-market/inquire-before-buying
Market Segmentation
The blood preparation market is segmented based on product type, antithrombotic & anticoagulant types, application, end-user, and geographic region. Key product categories include whole blood, blood components, and blood derivatives. Whole blood is further subdivided into granulocytes, red cells, platelets, and plasma, while blood components include packed red cells, frozen plasma, platelet concentrate, and cryoprecipitate. Blood derivatives include plasma-based treatments such as IVIg and Albumin.
By anticoagulant and antithrombotic types, the market is divided into anticoagulants, platelet aggregation inhibitors, and fibrinolytics, with key subcategories such as heparins, glycoprotein inhibitors, and tissue plasminogen activator (tPA).
Key applications driving demand include thrombocytosis, pulmonary embolism, renal impairment, and angina complications, with hospitals, blood banks, and pharmaceuticals being major end-users of blood preparation products.
Geographical Insights
North America is expected to retain its dominant share of the global blood preparation market, driven by the region’s advanced healthcare infrastructure, high surgical procedures, and the growing incidence of blood cancers like leukemia and lymphoma. According to the Leukemia Lymphoma Society (LLS), blood cancers accounted for 9.8% of all cancer cases diagnosed in the U.S. in 2021. With substantial healthcare spending and rising cancer prevalence, North America will remain a significant market for blood preparations.
Meanwhile, the Asia-Pacific region is witnessing steady market growth due to a rising geriatric population. As the elderly become more susceptible to conditions requiring blood transfusions—such as cancer and cardiovascular diseases—the demand for blood products is expected to rise. In China, the elderly population is set to grow significantly in the coming decades, further fueling market growth in the region.
Competitive Landscape
The global blood preparation market is highly competitive, with several key players shaping the industry landscape. Leading companies in the market include GlaxoSmithKline plc, Baxter Healthcare Corp., Pfizer Inc., Bristol-Myers Squibb Company, and Sanofi Aventis. These companies are actively pursuing strategies like acquisitions to expand their product portfolios and strengthen their market presence.
For instance, in October 2022, Pfizer acquired Global Blood Therapeutics, a company focused on treatments for blood disorders, to enhance its presence in the rare disease market. Similarly, GlaxoSmithKline acquired Sierra Oncology in July 2022 to diversify its oncology portfolio with therapies for rare cancers.
Conclusion
The global blood preparation market is poised for robust growth over the next several years, fueled by technological advancements, the increasing use of plasma-based therapies, and the rising demand for blood products. However, challenges such as disease transmission risks and allergic reactions remain. Nonetheless, the continuous development of innovative solutions offers significant opportunities for the market.
Also, Browse Related Reports:
For more information, please contact:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com
Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube
About Next Move Strategy Consulting:
Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.